Loading video...

Video Failed to Load

Go Home

Ivermectin + Mebendazole: The Cancer Study That Changes the Conversation. Two anti-infective drugs. Both already FDA-approved. Both already widely available. Together they reduce cancer cell proliferation, cut off the tumor's blood supply, and trigger cancer cell self-termination. 84% net clinical benefit across prostate, breast, and lung cancer patients. The...

McCulloughFund's profile picture

McCullough Foundation

76,312 subscribers

15,826 views • 3 months ago •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom
0:54

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

15,960 views • 2 months ago

A Cancer Study With 84% Positive Results. The NIH Should Have Done This. Nearly 200 patients. Prostate. Breast. Lung. Solid organ cancers — many already metastatic. 48% reported regression. 36% held stable. The combination is widely available, inexpensive, and now under peer review. The National Cancer Institute still hasn't moved. The question is why. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:39

A Cancer Study With 84% Positive Results. The NIH Should Have Done This. Nearly 200 patients. Prostate. Breast. Lung. Solid organ cancers — many already metastatic. 48% reported regression. 36% held stable. The combination is widely available, inexpensive, and now under peer review. The National Cancer Institute still hasn't moved. The question is why. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

40,509 views • 3 months ago

Cancer Breakthrough: Two Cheap Generic Drugs. One Stunning Combination. Ivermectin and mebendazole — both FDA-approved, both widely available, both dirt cheap — are showing results in solid organ cancers that expensive chemotherapy protocols can't match on safety alone. Large-scale randomized trials are the next step. The data is already there to justify them. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:36

Cancer Breakthrough: Two Cheap Generic Drugs. One Stunning Combination. Ivermectin and mebendazole — both FDA-approved, both widely available, both dirt cheap — are showing results in solid organ cancers that expensive chemotherapy protocols can't match on safety alone. Large-scale randomized trials are the next step. The data is already there to justify them. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

22,810 views • 3 months ago

Anti-Parasitic. Anti-Viral. Anti-Cancer. Two Drugs Already in Your Pharmacy. Ivermectin and mebendazole were developed to fight parasites. Then studies found they also had antiviral properties. Now a patient-reported outcomes study shows anti-cancer effects across nearly 200 patients. The same mechanisms that starve parasites — cutting off proliferation, blocking blood supply, triggering cell death — work on cancer cells too. The science was there. Nobody funded the trials. Join the Fight: Courtesy of The Amber May Show #MedicalFreedom
2:11

Anti-Parasitic. Anti-Viral. Anti-Cancer. Two Drugs Already in Your Pharmacy. Ivermectin and mebendazole were developed to fight parasites. Then studies found they also had antiviral properties. Now a patient-reported outcomes study shows anti-cancer effects across nearly 200 patients. The same mechanisms that starve parasites — cutting off proliferation, blocking blood supply, triggering cell death — work on cancer cells too. The science was there. Nobody funded the trials. Join the Fight: Courtesy of The Amber May Show #MedicalFreedom

McCullough Foundation

31,580 views • 2 months ago

Ivermectin and Mebendazole Cost a Fraction of Chemo. Big Pharma Can't Patent Them. That's the Problem. Cancer centers get a cut of every chemotherapy bill. Generic drugs don't generate that margin. Two affordable, widely available compounds showing 84% clinical benefit in a real-world cancer cohort still don't have a single large-scale randomized trial behind them — not because the science isn't there, but because the incentive structure isn't. The National Cancer Institute needs to run the trial. The patients can't keep waiting. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Steve Gruber Daybreak, The Steve Gruber Show Steve Gruber #MedicalFreedom
1:13

Ivermectin and Mebendazole Cost a Fraction of Chemo. Big Pharma Can't Patent Them. That's the Problem. Cancer centers get a cut of every chemotherapy bill. Generic drugs don't generate that margin. Two affordable, widely available compounds showing 84% clinical benefit in a real-world cancer cohort still don't have a single large-scale randomized trial behind them — not because the science isn't there, but because the incentive structure isn't. The National Cancer Institute needs to run the trial. The patients can't keep waiting. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Steve Gruber Daybreak, The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

33,132 views • 2 months ago

Ivermectin + Mebendazole Is Outperforming Cancer Treatments Nobody Can Afford. 48% reported actual tumor regression. 36% held stable. Only 15% worsened — in a population of nearly 200 solid organ cancer patients, many already widely metastatic. These are preliminary patient-reported outcomes. They are also the most encouraging cancer data most people haven't heard about. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon #MedicalFreedom
1:27

Ivermectin + Mebendazole Is Outperforming Cancer Treatments Nobody Can Afford. 48% reported actual tumor regression. 36% held stable. Only 15% worsened — in a population of nearly 200 solid organ cancer patients, many already widely metastatic. These are preliminary patient-reported outcomes. They are also the most encouraging cancer data most people haven't heard about. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon #MedicalFreedom

McCullough Foundation

23,979 views • 3 months ago

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom
1:37

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom

McCullough Foundation

194,062 views • 2 months ago

Even the Minority Witness at Ron Johnson's Cancer Senate Hearings Had to Agree: COVID Vaccines Appear to Be Causing Cancer in Some People. Breast. Female reproductive. Colon cancer in women. Prostate. Lung. Colorectal in men. Cancer has been rising for two decades — but the curves have now taken a hockey stick upward inflection. The Senate hearing brought UK and US cancer experts together, and the conclusion was not disputed across party lines. Screen now. Re-screen. Total body MRI technology exists. We need to be ahead of this — because too many people are already at risk. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
0:53

Even the Minority Witness at Ron Johnson's Cancer Senate Hearings Had to Agree: COVID Vaccines Appear to Be Causing Cancer in Some People. Breast. Female reproductive. Colon cancer in women. Prostate. Lung. Colorectal in men. Cancer has been rising for two decades — but the curves have now taken a hockey stick upward inflection. The Senate hearing brought UK and US cancer experts together, and the conclusion was not disputed across party lines. Screen now. Re-screen. Total body MRI technology exists. We need to be ahead of this — because too many people are already at risk. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

15,144 views • 6 days ago

Cancer Patients Have No Generic Options. Everything Must Be Branded. Offered Through a Cancer Center. After 40 Years in Practice, the Suspicion Is Now Intentional Suppression. Ivermectin and mebendazole — cheap, widely available, showing 84% clinical benefit in cancer patients — are not offered through a single cancer center in the country. Everything in oncology must be branded, patented, and administered through a book-and-bill relationship that profits the center. The biomedical deep state didn't disappear with the new administration. Vaccine reform has been slower than promised. The mRNA platform has been green-lit for RSV and influenza without preclinical safety testing. The machine is still running. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:26

Cancer Patients Have No Generic Options. Everything Must Be Branded. Offered Through a Cancer Center. After 40 Years in Practice, the Suspicion Is Now Intentional Suppression. Ivermectin and mebendazole — cheap, widely available, showing 84% clinical benefit in cancer patients — are not offered through a single cancer center in the country. Everything in oncology must be branded, patented, and administered through a book-and-bill relationship that profits the center. The biomedical deep state didn't disappear with the new administration. Vaccine reform has been slower than promised. The mRNA platform has been green-lit for RSV and influenza without preclinical safety testing. The machine is still running. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

14,426 views • 8 days ago

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year — use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact — cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise John Solomon Amanda Head #MedicalFreedom
0:54

JAMA Reported That Ivermectin and Mebendazole Use in Cancer Patients Has Skyrocketed. The NCI Has Been Watching. Now They Need to Act. A report from Rockwell and colleagues in JAMA confirms what patient data has been showing for over a year — use of ivermectin and mebendazole among cancer patients surged through 2025. Mel Gibson's appearance on Joe Rogan accelerated it further. The first clinical report shows 84% positive impact — cancers held stable or improved when the combination was added to traditional care. The National Cancer Institute is tracking this. The next step is a large prospective randomized double-blind placebo-controlled trial. The data is there. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise John Solomon Amanda Head #MedicalFreedom

McCullough Foundation

20,062 views • 1 month ago

Nearly One in Two Cancer Patients Saw Their Cancer Go Into Remission or Improve. Let That Sink In. Not stable. Not managed. Remission or improvement — in a real-world cohort of nearly 200 cancer patients on off-label ivermectin and mebendazole. The study is under peer review. The drugs are already on pharmacy shelves. The National Cancer Institute has an obligation to take this to a large-scale controlled trial immediately. Join the Fight: Courtesy of Newsmax NEWSMAX, Katrina Szish KATRINA SZISH, Bob Brooks Bob Brooks #MedicalFreedom
1:16

Nearly One in Two Cancer Patients Saw Their Cancer Go Into Remission or Improve. Let That Sink In. Not stable. Not managed. Remission or improvement — in a real-world cohort of nearly 200 cancer patients on off-label ivermectin and mebendazole. The study is under peer review. The drugs are already on pharmacy shelves. The National Cancer Institute has an obligation to take this to a large-scale controlled trial immediately. Join the Fight: Courtesy of Newsmax NEWSMAX, Katrina Szish KATRINA SZISH, Bob Brooks Bob Brooks #MedicalFreedom

McCullough Foundation

44,490 views • 2 months ago

What Is a Turbo Cancer? A Cardiologist With 40 Years of Practice Says He's Never Seen Anything Like It. Younger patients. More aggressive at presentation. Progressing faster than anything in the textbooks. A bladder cancer so rapidly growing an entire organ had to be removed. Colon cancer now the leading cancer in men under 45. Turbo cancer isn't a fringe term — it's a clinical observation being documented across practices nationwide, and the pattern is new. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:04

What Is a Turbo Cancer? A Cardiologist With 40 Years of Practice Says He's Never Seen Anything Like It. Younger patients. More aggressive at presentation. Progressing faster than anything in the textbooks. A bladder cancer so rapidly growing an entire organ had to be removed. Colon cancer now the leading cancer in men under 45. Turbo cancer isn't a fringe term — it's a clinical observation being documented across practices nationwide, and the pattern is new. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

18,463 views • 2 months ago

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom
1:17

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom

McCullough Foundation

17,960 views • 2 months ago

Generic Drugs With Decades of Safety Data. Promising Early Results. Still No Large Trials. That Needs to Change Now. Ivermectin. Mebendazole. Repurposed compounds with established safety profiles and mounting evidence of efficacy — in cancer, in infection, in chronic disease. The pipeline for large-scale trials exists. The incentive structure doesn't support it. RFK and the National Cancer Institute have an opportunity to fast-track what Big Pharma won't touch. The data is ready. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon, Amanda Head Amanda Head #MedicalFreedom
0:35

Generic Drugs With Decades of Safety Data. Promising Early Results. Still No Large Trials. That Needs to Change Now. Ivermectin. Mebendazole. Repurposed compounds with established safety profiles and mounting evidence of efficacy — in cancer, in infection, in chronic disease. The pipeline for large-scale trials exists. The incentive structure doesn't support it. RFK and the National Cancer Institute have an opportunity to fast-track what Big Pharma won't touch. The data is ready. The patients can't wait. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Just The News No Noise, John Solomon John Solomon, Amanda Head Amanda Head #MedicalFreedom

McCullough Foundation

11,283 views • 2 months ago

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.

Nicolas Hulscher, MPH

100,474 views • 3 months ago

Social Media Knew About Ivermectin and Cancer Before the Institutions Did. That Should Embarrass Them. Patients were already talking about it. Requesting it. Using it. A private company tracked the outcomes because no major research body would. Now Johns Hopkins and Cedars-UCLA are finally running protocols. The conversation started in the places they told you not to trust. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom
1:11

Social Media Knew About Ivermectin and Cancer Before the Institutions Did. That Should Embarrass Them. Patients were already talking about it. Requesting it. Using it. A private company tracked the outcomes because no major research body would. Now Johns Hopkins and Cedars-UCLA are finally running protocols. The conversation started in the places they told you not to trust. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Live From Studio 6B Live From Studio 6B #MedicalFreedom

McCullough Foundation

29,220 views • 3 months ago

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).

Joe Tippens

30,145 views • 3 months ago

Patterns in Cancer That Have Never Been Seen Before. Time Magazine Put It on the Cover. Nobody Connected the Dots. Multiple cancer types in a single patient. Colon cancer rising in men under 45. Cancers appearing at younger ages, progressing faster, presenting more severely. Time Magazine described the phenomenon without naming a cause. The clinical data pointing to a post-pandemic origin has been in the peer-reviewed literature for two years. The mainstream press still won't say it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom
1:33

Patterns in Cancer That Have Never Been Seen Before. Time Magazine Put It on the Cover. Nobody Connected the Dots. Multiple cancer types in a single patient. Colon cancer rising in men under 45. Cancers appearing at younger ages, progressing faster, presenting more severely. Time Magazine described the phenomenon without naming a cause. The clinical data pointing to a post-pandemic origin has been in the peer-reviewed literature for two years. The mainstream press still won't say it. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), Faith and Freedom, Shemane Nugent Shemane Nugent #MedicalFreedom

McCullough Foundation

27,141 views • 2 months ago

Increasing Mechanistic Data Support COVID-19 Vaccine Turbo-Cancer Hypothesis The National Cancer Institute should urgently investigate the oncogenicity of long-lasting synthetic mRNA and the impact of years of Spike protein exposure to both immune and somatic cells. Courtesy Steve Gruber Show, Real America's Voice. Steve Gruber Real America's Voice (RAV) Kevin McKernan McCullough Foundation M. Nathaniel Mead, MSc, PhD Claire Rogers Kirstin Cosgrove Breanne Craven PA-C Simon Troupe, MPH Nicolas Hulscher, MPH John Leake
0:59

Increasing Mechanistic Data Support COVID-19 Vaccine Turbo-Cancer Hypothesis The National Cancer Institute should urgently investigate the oncogenicity of long-lasting synthetic mRNA and the impact of years of Spike protein exposure to both immune and somatic cells. Courtesy Steve Gruber Show, Real America's Voice. Steve Gruber Real America's Voice (RAV) Kevin McKernan McCullough Foundation M. Nathaniel Mead, MSc, PhD Claire Rogers Kirstin Cosgrove Breanne Craven PA-C Simon Troupe, MPH Nicolas Hulscher, MPH John Leake

Peter A. McCullough, MD, MPH®

113,967 views • 10 months ago

Time Magazine Asked Why Young People Are Getting Cancer. Not One Doctor They Interviewed Mentioned the Pandemic. Not one. A 300-study analysis published in Oncotarget concluded both the COVID virus and the vaccines are linked to rising cancer rates — through suppression of P53 and BRCA cancer surveillance systems. Colon. Prostate. Breast. All rising in younger patients. The five alarm fire is already burning. The institutions are still looking the other way. Join the Fight: Courtesy of Dr. Dustin Show of Eclipse Pain and Recovery. #EclipsePainNetwork Watch the Full Conversation: #MedicalFreedom
1:06

Time Magazine Asked Why Young People Are Getting Cancer. Not One Doctor They Interviewed Mentioned the Pandemic. Not one. A 300-study analysis published in Oncotarget concluded both the COVID virus and the vaccines are linked to rising cancer rates — through suppression of P53 and BRCA cancer surveillance systems. Colon. Prostate. Breast. All rising in younger patients. The five alarm fire is already burning. The institutions are still looking the other way. Join the Fight: Courtesy of Dr. Dustin Show of Eclipse Pain and Recovery. #EclipsePainNetwork Watch the Full Conversation: #MedicalFreedom

McCullough Foundation

12,821 views • 2 months ago